We’ve discussed Minicircle, the Roatan, Honduras based startup that is doing private gene therapy (and other) clinical trials for longevity, etc. See these past discussions:
Here: Follistatin injections via Minicircle plasmids? They're recruiting new volunteers for trials in Honduras
Here: Longevity Clinics: What They Are, Services & More
Here: Edit Human DNA at Home With a DIY CRISPR Kit
If anyone visiting our site has participated in any of these trials at Minicircle, please post information about your experiences and outcomes.
Now the MIT Technology Review is covering them in this new article:
The advertisement—posted on Mirror, a Web3 publishing platform, in March last year—outlined an eye-catching if perhaps confusing proposal: “Access NFTs for a follistatin plasmid phase I clinical trial in Prospera ZEDE, Honduras.”
The ad had been posted by a biotech startup called Minicircle, which was recruiting participants for a clinical trial of gene therapy. But several details made it unusual. For one, it instructed would-be guinea pigs to purchase an NFT to take part. Upon completing the study, it promised, they would receive payment in cryptocurrency. And while it notes the geographical location of the trial, test subjects may not have immediately understood that it would get underway in what is essentially an experimental crypto city—Próspera, Honduras.
The unconventional recruitment effort marked a curious development in the space of gene therapy, a cutting-edge field that has endured decades of false starts and setbacks. FDA-approved gene therapy treatments remain rare, but those breaking through come with eye-watering price tags, in part because of the cost and complexity involved in their creation.
Full article here:
2020 Podcast Interview with the Founder of Minicircle: Mac Davis: